Peter Rothschild
(Mr. Peter Rothschild)
Currently holds positions in Biogaia AB and Infant Bacterial Therapeutics AB
Positions
| Position | Company | Period |
|---|---|---|
| Chairman of the Board | Biogaia AB | April 25, 2018 - |
| Chairman of the Board | Infant Bacterial Therapeutics AB | None - |
| Group President | Biogaia AB | March 1, 2016 - April 25, 2018 |
| Chief Executive Officer | Biogaia AB | Jan. 1, 1996 - March 1, 2016 |
| Independent Director | Moberg Pharma AB (publ) | April 18, 2011 - May 13, 2014 |
Search
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
| Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
|---|---|---|---|---|---|---|---|---|
| May 6, 2021 | May 4, 2021 |
|
B Purchase |
100,000
93.309,330,000 SEK |
100,000 | 93.30 | 9,330,000 SEK | |
| Nov. 26, 2018 | Nov. 23, 2018 |
|
S Sale |
92,404
344.0031,786,976 SEK |
92,404 | 344.00 | 31,786,976 SEK | |
| Nov. 22, 2018 | Nov. 22, 2018 |
|
S Sale |
52,896
344.0018,196,224 SEK |
52,896 | 344.00 | 18,196,224 SEK | |
| Dec. 11, 2017 | Dec. 7, 2017 |
|
S Sale |
250,000
290.0072,500,000 SEK |
250,000 | 290.00 | 72,500,000 SEK |